A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...

The findings on the Ayurvedic treatment of liver cirrhosis have been formally recognized in the scientific community, with ...

A new drug application seeking the approval of ziftomenib was submitted to the FDA on April 8, 2025. This indication is for ...

The researchers then investigated how the metabolisms of treated mice changed. They found that the effect was caused by ...

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Metabolic liver disease might not get as much attention as heart disease or diabetes, but it affects around one in four ...

The cutting-edge weight-loss drug Ozempic/Wegovy can stop and even reverse fatty liver disease, a new clinical trial has ...